Grace Therapeutics’ lead clinical asset, GTx-104, is an intravenous infusion targeting aneurysmal Subarachnoid Hemorrhage (aSAH), a rare and life-threatening medical emergency in which bleeding occurs ...

The global sales of central venous catheters (CVC) are estimated to be valued at USD 2,861.0 million in 2024 and are expected ...

Preclinical data demonstrated durable immune responses and tumor growth inhibition with Mural's IL-18 variants, reinforcing ...

A one-volume commentary and a two-volume set on African American Christianity highlight the mission and vision of ...

Since the North Cove plant went offline, hospitals across the country have faced disruption in the supply of some sterile ...

Florida Sens. Marco Rubio (R) and Rick Scott (R) are questioning why the Biden administration hasn’t done more to leverage ...

Scottsdale police arrested Jason Imhoff and accused him of sex crimes during an undercover operation where a detective posed as a 13-year-old girl.

is an intravenous infusion targeting aneurysmal Subarachnoid Hemorrhage (aSAH), a rare and life-threatening medical emergency in which bleeding occurs over the surface of the brain in the subarachnoid ...

Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (”Inspire” or the “Company”), an owner and provider of pet health care ...

About IV Choline Chloride IV Choline Chloride is an investigational, intravenous phospholipid substrate replacement therapy in development ... For more information, visit www.protaratx.com. Statements ...